IDXX
IDEXX Laboratories, Inc.
Stock
$518.39+0.64 (+0.12%)Close Oct 2, 2026
- Operating income, 2025
- $1.4B
- YoY, 2025
- +20.5%
- 5-year CAGR
- +14.4%
- 10-year CAGR
- +16.3%
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| 2025 | $1.4B | +20.5% |
| 2024 | $1.1B | +2.8% |
| 2023 | $1.1B | +22.1% |
| 2022 | $899M | −3.6% |
| 2021 | $932M | +34.2% |
| 2020 | $695M | +25.6% |
| 2019 | $553M | +12.5% |
| 2018 | $491M | +19.0% |
| 2017 | $413M | +17.9% |
| 2016 | $350M | +16.8% |
| 2015 | $300M | +15.2% |
| 2014 | $260M | −2.4% |
| 2013 | $267M | +1.6% |
| 2012 | $263M | +11.1% |
| 2011 | $236M | +15.9% |
| 2010 | $204M | +15.9% |
| 2009 | $176M | +2.0% |
| 2008 | $172M | — |